| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 78.355 | 81.680 | 81.154 | 101.052 | 112.588 |
| Total Income - EUR | - | - | - | - | 0 | 78.355 | 81.681 | 81.156 | 101.052 | 112.589 |
| Total Expenses - EUR | - | - | - | - | 643 | 61.843 | 76.187 | 78.258 | 84.480 | 127.063 |
| Gross Profit/Loss - EUR | - | - | - | - | -643 | 16.512 | 5.494 | 2.898 | 16.572 | -14.473 |
| Net Profit/Loss - EUR | - | - | - | - | -643 | 15.781 | 4.693 | 2.087 | 15.562 | -17.851 |
| Employees | - | - | - | - | 0 | 4 | 4 | 4 | 7 | 7 |
Check the financial reports for the company - Dr. Hisham Tageldin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 403 | 25.732 | 19.494 | 145.869 | 137.040 |
| Current Assets | - | - | - | - | 242 | 19.648 | 14.527 | 15.693 | 22.116 | 15.283 |
| Inventories | - | - | - | - | 0 | 477 | 466 | 973 | 970 | 965 |
| Receivables | - | - | - | - | 0 | 6.044 | 7.564 | 7.657 | 16.292 | 2.420 |
| Cash | - | - | - | - | 242 | 13.127 | 6.496 | 7.063 | 4.854 | 11.898 |
| Shareholders Funds | - | - | - | - | -601 | 15.192 | 15.303 | 13.837 | 21.270 | 1.092 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 843 | 4.859 | 24.956 | 21.357 | 146.714 | 151.230 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Hisham Tageldin Srl